Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group.

Dimopoulos MA, Terpos E, Chanan-Khan A, Leung N, Ludwig H, Jagannath S, Niesvizky R, Giralt S, Fermand JP, Bladé J, Comenzo RL, Sezer O, Palumbo A, Harousseau JL, Richardson PG, Barlogie B, Anderson KC, Sonneveld P, Tosi P, Cavo M, Rajkumar SV, Durie BG, San Miguel J.

J Clin Oncol. 2010 Nov 20;28(33):4976-84. doi: 10.1200/JCO.2010.30.8791. Review.

PMID:
20956629
2.

Novel therapeutic agents for the management of patients with multiple myeloma and renal impairment.

Chanan-Khan AA, San Miguel JF, Jagannath S, Ludwig H, Dimopoulos MA.

Clin Cancer Res. 2012 Apr 15;18(8):2145-63. doi: 10.1158/1078-0432.CCR-11-0498. Review.

3.

Pathogenesis and treatment of renal failure in multiple myeloma.

Dimopoulos MA, Kastritis E, Rosinol L, Bladé J, Ludwig H.

Leukemia. 2008 Aug;22(8):1485-93. doi: 10.1038/leu.2008.131. Review.

PMID:
18528426
4.

Treatment of patients with multiple myeloma complicated by renal failure with bortezomib-based regimens.

Roussou M, Kastritis E, Migkou M, Psimenou E, Grapsa I, Matsouka C, Barmparousi D, Terpos E, Dimopoulos MA.

Leuk Lymphoma. 2008 May;49(5):890-5. doi: 10.1080/10428190801930506. Review.

PMID:
18464107
5.

The emerging role of novel therapies for the treatment of relapsed myeloma.

Richardson PG, Hideshima T, Mitsiades C, Anderson KC.

J Natl Compr Canc Netw. 2007 Feb;5(2):149-62. Review.

PMID:
17335684
6.
7.

Management of myeloma-associated renal dysfunction in the era of novel therapies.

Gaballa MR, Laubach JP, Schlossman RL, Redman K, Noonan K, Mitsiades CS, Ghobrial IM, Munshi N, Anderson KC, Richardson PG.

Expert Rev Hematol. 2012 Feb;5(1):51-66; quiz 67-8. doi: 10.1586/ehm.11.72. Review.

PMID:
22272706
8.

New developments in the treatment of patients with multiple myeloma.

Minnema MC, van der Spek E, van de Donk NW, Lokhorst HM.

Neth J Med. 2010 Jan;68(1):24-32. Review.

9.

[New treatment strategy of multiple myeloma for cure].

Murakami H, Handa H.

Gan To Kagaku Ryoho. 2006 Apr;33(4):417-23. Review. Japanese.

PMID:
16612147
10.

Treatment of multiple myeloma: an emphasis on new developments.

Kyle RA, Vincent Rajkumar S.

Ann Med. 2006;38(2):111-5. Review.

PMID:
16581696
11.

Treatment of multiple myeloma in the targeted therapy era.

Saad AA, Sharma M, Higa GM.

Ann Pharmacother. 2009 Feb;43(2):329-38. doi: 10.1345/aph.1L428. Review.

PMID:
19193585
12.

[New insights in the treatment of myeloma with renal failure].

Moumas E, Hanf W, Desport E, Abraham J, Delbès S, Debiais C, Lacotte-Thierry L, Touchard G, Jaccard A, Fermand JP, Bridoux F.

Nephrol Ther. 2011 Nov;7(6):457-66. doi: 10.1016/j.nephro.2011.03.002. Review. French.

PMID:
21515102
13.

Bortezomib in the front-line treatment of multiple myeloma.

Richardson PG, Mitsiades C, Schlossman R, Ghobrial I, Hideshima T, Munshi N, Anderson KC.

Expert Rev Anticancer Ther. 2008 Jul;8(7):1053-72. doi: 10.1586/14737140.8.7.1053. Review.

PMID:
18588451
14.

Treatment of myeloma in patients not eligible for transplantation.

Jagannath S.

Curr Treat Options Oncol. 2005 May;6(3):241-53. Review.

PMID:
15869735
15.

Renal failure in multiple myeloma: a medical emergency.

Wirk B.

Bone Marrow Transplant. 2011 Jun;46(6):771-83. doi: 10.1038/bmt.2011.8. Review.

PMID:
21339749
16.

Initial Therapy of Multiple Myeloma in Patients who are Candidates for Stem Cell Transplantation.

Bensinger W.

Curr Treat Options Oncol. 2007 Apr;8(2):135-43. Review.

PMID:
17721746
17.

Advances in therapy of multiple myeloma.

Bladé J, Rosiñol L.

Curr Opin Oncol. 2008 Nov;20(6):697-704. doi: 10.1097/CCO.0b013e3283136984. Review.

PMID:
18841053
18.

Myeloma kidney: improving clinical outcomes?

Haynes R, Leung N, Kyle R, Winearls CG.

Adv Chronic Kidney Dis. 2012 Sep;19(5):342-51. doi: 10.1053/j.ackd.2012.03.001. Review.

PMID:
22920645
19.

Management of older patients with multiple myeloma.

Gay F, Palumbo A.

Blood Rev. 2011 Mar;25(2):65-73. doi: 10.1016/j.blre.2010.10.003. Review.

PMID:
21295387
20.

Current treatments for renal failure due to multiple myeloma.

Kastritis E, Terpos E, Dimopoulos MA.

Expert Opin Pharmacother. 2013 Aug;14(11):1477-95. doi: 10.1517/14656566.2013.803068. Review.

PMID:
23705905
Items per page

Supplemental Content

Support Center